These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1222 related articles for article (PubMed ID: 18500230)

  • 41. New genes in inflammatory bowel disease: lessons for complex diseases?
    Gaya DR; Russell RK; Nimmo ER; Satsangi J
    Lancet; 2006 Apr; 367(9518):1271-84. PubMed ID: 16631883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostics of inflammatory bowel disease.
    Nikolaus S; Schreiber S
    Gastroenterology; 2007 Nov; 133(5):1670-89. PubMed ID: 17983810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The expanding universe of inflammatory bowel disease genetics.
    Achkar JP; Duerr R
    Curr Opin Gastroenterol; 2008 Jul; 24(4):429-34. PubMed ID: 18622155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unravelling the complex genetics of inflammatory bowel disease.
    Russell RK; Wilson DC; Satsangi J
    Arch Dis Child; 2004 Jul; 89(7):598-603. PubMed ID: 15210486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammatory bowel disease: progress and current concepts of etiopathogenesis.
    Scaldaferri F; Fiocchi C
    J Dig Dis; 2007 Nov; 8(4):171-8. PubMed ID: 17970872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New IBD genetics: common pathways with other diseases.
    Lees CW; Barrett JC; Parkes M; Satsangi J
    Gut; 2011 Dec; 60(12):1739-53. PubMed ID: 21300624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Polygenetic disturbance in the front line mucosa defense].
    Söderholm JD; Pettersson S
    Lakartidningen; 2009 Nov 4-12; 106(45):2974, 2976-8. PubMed ID: 19998821
    [No Abstract]   [Full Text] [Related]  

  • 49. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
    Gehlert T; Devergne O; Niedobitek G
    J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The eye and chronic inflammatory diseases of the intestines. Immunopathological and genetic aspects. Apropos of 3 cases].
    Raby O; Salvanet-Bouccara A; Forestier F
    J Fr Ophtalmol; 1987; 10(11):683-98. PubMed ID: 3329203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
    Brand S
    Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
    Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
    Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
    Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Anxiety and depression in ulcerative colitis and Lesniovsky-Crohn's disease].
    Kamrowska A; Kasprzak K; Marciniak J; Goch A; Kamrowski C
    Pol Merkur Lekarski; 2010 Mar; 28(165):239-41. PubMed ID: 20815177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The genetics of chronic inflammatory diseases.
    Heap GA; van Heel DA
    Hum Mol Genet; 2009 Apr; 18(R1):R101-6. PubMed ID: 19297396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of diarrhea in inflammatory bowel diseases.
    Binder HJ
    Ann N Y Acad Sci; 2009 May; 1165():285-93. PubMed ID: 19538318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defensin-immunology in inflammatory bowel disease.
    Wehkamp J; Stange EF; Fellermann K
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory bowel disease and smoking--a review.
    Thomas GA; Rhodes J; Green JT
    Am J Gastroenterol; 1998 Feb; 93(2):144-9. PubMed ID: 9468230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.